A studio service
BIO-Europe presentation design for thirty minutes across a table.
Next: 9–11 November 2026, Cologne. A partnering deck is not an investor deck with the logo swapped. It is read on a laptop by someone who has already sat through six meetings that morning, cannot sign a CDA yet, and is deciding in the first two minutes whether to book a follow-up. We design for that room.
Investment
Three ways to raise.
Fixed price, fixed scope. Pick the tier that matches your raise — from a single deal deck to a full capital-raise kit.
Essential
A focused deck for a single asset or a partnering round - you bring the data, we design it.
5-7 business days
- 12-15 designed slides
- Pipeline table and mechanism diagram
- Data figures redrawn to publication standard
- Every claim footnoted to your source
- 1 revision round
- Editable PowerPoint source files
Standard
The full raise or partnering push: we shape the narrative, build the figures and cut the short version.
Priority - 4-5 business days
- 18-25 designed slides
- We build the narrative from your inputs
- Full figure set - efficacy, safety, IP timeline
- Non-confidential partnering version
- 2 revision rounds
- Editable PowerPoint + source files
Complete
Everything a conference season needs - deck, appendix, one-pager and the data-room set.
Rush available
- 30-50 slides - deck plus appendix
- Company presentation and partnering versions
- Non-confidential one-pager for the leave-behind
- Data-room slide set
- 3 revision rounds, white-glove
- 60-minute strategy call + all source files
N° 01The calendar
Where this deck is going to be read.
Dates as published by the organisers. Meeting schedules firm up a few weeks out, which is when most teams discover how many meetings they actually have — that is usually the wrong moment to start building.
01
BIO-Europe 2026
9–11 November 2026, Cologne. Digital partnering 17–18 November.
02
RESI 2026
22–23 September 2026, Boston. Virtual partnering 25 and 28–29 September.
03
TechCrunch Disrupt 2026
13–15 October 2026, San Francisco. Startup Battlefield 200; finalists announced on day one.
04
Slush 2026
18–19 November 2026, Helsinki. Investor Day and Day 0 for Founders on 17 November.
05
EIC Accelerator cut-off 2026
2 September 2026. Full-proposal cut-off; jury interviews follow roughly 10–12 weeks later.
06
EIC Accelerator cut-off 2026
4 November 2026. Full-proposal cut-off; jury interviews follow roughly 10–12 weeks later.
07
BIO-Europe 2027
Autumn 2027, dates to be announced
08
BIO-Europe Spring 2027
5–8 April 2027, Lyon
09
J.P. Morgan Healthcare Conference 2027
11–14 January 2027, San Francisco. The 45th annual meeting.
10
Biotech Showcase 2027
11–13 January 2027, San Francisco. Digital partnering 19–20 January.
11
RESI 2027
11–12 January 2027, San Francisco. JPM-week edition; virtual partnering 13 and 18–19 January.
12
BIO Partnering at JPM Week 2027
11–14 January 2027, San Francisco. Scheduled one-on-one partnering only — no podium track.
13
LSI USA Emerging Medtech Summit 2027
15–19 March 2027, Dana Point, California
14
Hello Tomorrow Global Summit 2027
2027 edition dates not yet published
15
BIO International Convention 2027
7–10 June 2027, Philadelphia
16
BIO International Convention 2028
12–15 June 2028, San Diego
N° 02What the format demands
Four constraints that change the design.
01
Thirty minutes, and they are not all yours
A partneringONE slot includes introductions, their questions and the conversation about what happens next. The deck gets maybe fifteen minutes, often less. Ten to twelve slides with an appendix you can jump to beats forty slides you never reach.
02
No CDA yet
First meetings usually happen before confidentiality is in place, so the deck has to persuade without the things you most want to show. Designing around that — masked structures, stage markers instead of figures, published data doing the heavy lifting — is most of the work.
03
A laptop, not a projector
Partnering meetings happen at a small table in a hall with a few thousand other conversations in it. Eight-point footnotes and pale grey axis labels disappear. Everything that matters has to survive a thirteen-inch screen turned sideways.
04
Run back to back, for days
The same deck gets presented twenty or thirty times to audiences that want different things — a pharma scout, a licensing lead, a VC. It needs to be navigable out of order, because half your meetings will not follow it.
N° 03What we build
Three documents, one story.
01
The partnering deck
The ten-to-twelve-slide core: asset, mechanism, stage, data, IP position and a specific ask. Built so any slide can be the first one you show when the meeting starts with their question instead of your opening.
02
The company presentation
The one-to-many version for a presentation slot — a shorter, denser talk to a room that is part business development and part investor. Same substance, different structure, because a room is not a table.
03
The non-confidential one-pager
What they take back to the team. This is the document that gets read without you there and forwarded to the people who were not in the meeting, which arguably makes it the most important thing you hand over.
04
The appendix you hope to need
Extra data, additional programmes, the manufacturing slide, the detailed IP timeline. Never presented linearly, indexed so you can reach any of it in one click when someone asks the good question.
N° 04Who this is for
Every side of the table.
01
Out-licensing a clinical or preclinical asset
The deck has to make the asset legible to someone evaluating it against a dozen others that week — indication, stage, differentiation and what you are actually asking for, before the mechanism.
02
Platform companies seeking partners
The hardest to present, because the platform is the point but the partner buys a programme. We design so the technology and a concrete first application argue together.
03
Raising alongside partnering
Many teams take investor meetings in the same week. The story should be consistent without being the same file; we build the versions so they cannot drift apart.
04
Business development at established companies
In-licensing, co-development and regional rights. Less about the raise, more about making a complex proposition clear in the time available.
Sample slides
Sample slides, in house style.
Generated in our editorial discipline — framed to your vertical. Every deck we ship is original and bespoke.
Questions
The answers we give most often.
- How long should a BIO-Europe partnering deck be?
- Ten to twelve slides. A thirty-minute meeting includes introductions, questions and next steps, so the deck has perhaps fifteen minutes. Most teams bring a forty-slide investor deck and never reach the ask. Build the short version; put the rest in an appendix you can jump to.
- What has to come out of a non-confidential deck?
- Unpublished structures, exact formulations, undisclosed targets, unfiled IP. That is a design problem as much as a legal one — the deck still has to persuade without them. Usually the answer is to lead with validated mechanism, disclosable data, development stage and the shape of the ask.
- Is the company presentation the same deck as the partnering meeting?
- No, and using one for both is the most common mistake. A presentation slot is one-to-many to a mixed room. A partnering meeting is one-to-one and driven by their questions rather than your running order. The content overlaps; the structure should not.
- Do you need our confidential data to design it?
- No. We work from what you can disclose without a CDA — the same constraint the deck operates under. Where something cannot be shown we design around it: a masked structure, a redacted axis, a stage marker instead of a figure.
- Can you also design the one-pager?
- Yes, and it is often worth more than the deck. It gets read without you in the room and forwarded to people who were not in the meeting. We design it as a companion to the deck, not a compressed copy of it.
- How late can we start before the conference?
- Tell us the date and we will tell you honestly whether it fits. Meeting schedules firm up a few weeks out, which is when most teams learn how many meetings they have. If the timeline is too tight to do properly, we will say so rather than rush it.
- Do you work on BIO-Europe Spring and other partnering conferences?
- Yes — BIO-Europe Spring, BIO International, JPM and Biotech Showcase share the format: short scheduled meetings, non-confidential material, a deck read on a laptop. A deck built for one travels to the others with minor edits.
- Do you understand the science?
- Enough to design it honestly, and not so much that we will pretend to peer-review your data. We ask a lot of questions, we footnote every claim to a source you give us, and we will tell you when a slide is claiming more than the data behind it supports.
Next step
Presenting at BIO-Europe?
Tell us the asset, how many meetings you have booked and what you can disclose without a CDA. We'll come back with the structure we would build and an honest answer on whether the timeline works.